Companies / Santa Cruz Biotechnology / TGF-β RI Kinase Inhibitor VIII
Santa Cruz Biotechnology

TGF-β RI Kinase Inhibitor VIII | Santa Cruz Biotechnology

ACTR-IB Inhibitor, COL1A1 Inhibitor, PAI-1 Inhibitor, TGF beta Receptor Inhibitor, TGF beta RI Inhibitor, TGF-β RI Kinase Inhibitor VIII is a potent ATP-competitive inhibitor against receptor TbR-I/ALK5

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.